Billings Clinic
Especially For:

Clinical Trials

Title   Lung Cancer: COX INHIBITOR COMPARISON
Description   "CALGB 30801 A RANDOMIZED PHASE III DOUBLE BLIND TRIAL EVALUATING SELECTIVE COX-2 INHIBITION IN COX-2
EXPRESSING ADVANCED NON-SMALL CELL LUNG CANCER"
IRB Number   CALGB 30801
Category   Lung Cancer
Inclusion/Notes   meas, or non meas. Squamous or non squamous histology, Gem/Carbo/celecoxib/placebo or pemetrexed/, no asaids, must send in tissue for COX 2 testing to qualify.
Status   Active
Start Date   09/10/2010
Principal Investigator (PI)   Jorge Nieva, MD
Contact Name   Judy Miller, RN
Contact Email   jmiller4@billingsclinic.org
Phone   (406) 435-7482
Fax   (000) 000-7489
Funding Source   NCI
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.